Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers - Evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases

Journal of Immunological Methods

Volumn 404, Issue 1, 2014, Pages 41-51

  Hentschel, Julia ^a   Müller, Ulrike ^a   Doht, Franziska ^a   Fischer, Nele ^a   Böer, Klas ^a   Sonnemann, Jürgen ^a   Hipler, Christina ^a   Hünniger, Kerstin ^b,c   Kurzai, Oliver ^b,c   Markert, Udo R ^a   Mainz, Jochen G ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Centrifugation; Cystic fibrosis; Cytokines; Cytology; Nasal lavage; Sampling technique

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; BACTERIAL INFECTION; BIOMETRY; CENTRIFUGATION; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL LINING FLUID; FREEZING; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTIPLEX BEAD ARRAY; NASAL LAVAGE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT PARAMETERS; SCHOOL CHILD; STORAGE; THAWING; UPPER RESPIRATORY TRACT; YOUNG ADULT;

BACTERIA (MICROORGANISMS);

CENTRIFUGATION; CYSTIC FIBROSIS; CYTOKINES; CYTOLOGY; NASAL LAVAGE; SAMPLING TECHNIQUE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CENTRIFUGATION; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; PEROXIDASE; PROTEASE INHIBITORS; SPECIMEN HANDLING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896714488     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.12.003     Document Type: Article

References (54)

1. Aanaes K., Johansen H.K., Skov M., Buchvald F.F., Hjuler T., Pressler T., Hoiby N., Nielsen K.G., von Buchwald C. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?. Rhinology 2013, 51:222.
2. Baumann R., Rabaszowski M., Stenin I., Gaertner-Akerboom M., Scheckenbach K., Wiltfang J., Schipper J., Wagenmann M. The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms. Clin. Transl. Allergy 2012, 2:13.
3. Beiersdorf N., Schien M., Hentschel J., Pfister W., Markert U.R., Mainz J.G. Soluble inflammation markers in nasal lavage from CF patients and healthy controls. J. Cyst. Fibros. 2013, 12(3):249-257. (Epub 2012 Sep 16). 10.1016/j.jcf.2012.08.015.
4. Belda J., Parameswaran K., Keith P.K., Hargreave F.E. Repeatability and validity of cell and fluid-phase measurements in nasal fluid: a comparison of two methods of nasal lavage. Clin. Exp. Allergy 2001, 31:1111.
5. Bergeron C., Hamid Q. Relationship between asthma and rhinitis: epidemiologic, pathophysiologic, and therapeutic aspects. Allergy, Asthma Clin. Immunol. 2005, 1:81.
6. Bergoin C., Gosset P., Lamblin C., Bolard F., Turck D., Tonnel A.B., Wallaert B. Cell and cytokine profile in nasal secretions in cystic fibrosis. J. Cyst. Fibros 2002, 1:110.
7. Berry L.J., Sheil B., Garratt L., Sly P.D. Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage. J. Cyst. Fibros 2010, 9:346.
8. Beule A.G. Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses. GMS Curr. Top. Otorhinolaryngol Head. Neck. Surg. 2010, 9:Doc07.
9. Biewenga J., Stoop A.E., Baker H.E., Swart S.J., Nauta J.J., van Kamp G.J., van der Baan S. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann. Clin. Biochem. 1991, 28(Pt 3):260.
10. Bresciani M., Paradis L., Des Roches A., Vernhet H., Vachier I., Godard P., Bousquet J., Chanez P. Rhinosinusitis in severe asthma. J. Allergy Clin. Immunol. 2001, 107:73.
11. Chawes B.L., Edwards M.J., Shamji B., Walker C., Nicholson G.C., Tan A.J., Folsgaard N.V., Bonnelykke K., Bisgaard H., Hansel T.T. A novel method for assessing unchallenged levels of mediators in nasal epithelial lining fluid. J. Allergy Clin. Immunol. 2010, 125(1387-1389):e3.
12. Deutschle T., Friemel E., Starnecker K., Riechelmann H. Nasal cytologies-impact of sampling method, repeated sampling and interobserver variability. Rhinology 2005, 43:215.
13. Digoy G.P., Dunn J.D., Stoner J.A., Christie A., Jones D.T. Bacteriology of the paranasal sinuses in pediatric cystic fibrosis patients. Int. J. Pediatr. Otorhinolaryngol. 2012, 76:934.
14. Eggesbo H.B., Sovik S., Dolvik S., Eiklid K., Kolmannskog F. CT characterization of developmental variations of the paranasal sinuses in cystic fibrosis. Acta Radiol. 2001, 42:482.
15. Erin E.M., Leaker B.R., Zacharasiewicz A.S., Higgins L.A., Williams T.J., Boyce M.J., de Boer P., Durham S.R., Barnes P.J., Hansel T.T. Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge. Allergy 2005, 60:1524.
16. Faurschou M., Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003, 5:1317.
17. Flower L., Ahuja R.H., Humphries S.E., Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 2000, 12:1712.
18. Fokkens W.J., Lund V.J., Mullol J., Bachert C., Alobid I., Baroody F., Cohen N., Cervin A., Douglas R., Gevaert P., Georgalas C., Goossens H., Harvey R., Hellings P., Hopkins C., Jones N., Joos G., Kalogjera L., Kern B., Kowalski M., Price D., Riechelmann H., Schlosser R., Senior B., Thomas M., Toskala E., Voegels R., Wang de Y., Wormald P.J. EPOS 2012: European position paper on rhinosinusitis and nasal polyps. A summary for otorhinolaryngologists. Rhinology 2012, 50:1.
19. Grobler A., Weitzel E.K., Buele A., Jardeleza C., Cheong Y.C., Field J., Wormald P.J. Pre- and postoperative sinus penetration of nasal irrigation. Laryngoscope 2008, 118:2078.
20. Gu L.C., Erdos E.A., Chiang H.S., Calderwood T., Tsai K., Visor G.C., Duffy J., Hsu W.C., Foster L.C. Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: analytical methods, kinetics, products, and solution formulation implications. Pharm. Res. 1991, 8:485.
21. Hager M., Cowland J.B., Borregaard N. Neutrophil granules in health and disease. J. Intern. Med. 2010, 268:25.
22. Hansen S.K., Rau M.H., Johansen H.K., Ciofu O., Jelsbak L., Yang L., Folkesson A., Jarmer H.O., Aanaes K., von Buchwald C., Hoiby N., Molin S. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J. 2012, 6(1):31-45. (Epub 2011 Jun 30). 10.1038/ismej.2011.83.
23. Hentschel Julia, Jäger Manuela, Beiersdorf Natalie, Fischer Nele, Doht Franziska, Michl Ruth K., Lehmann Thomas, Markert Udo R., Böer Klas, Keller Peter M., Pletz Mathias W., Mainz Jochen G. Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from Cystic Fibrosis patients during intravenous antibiotic treatment 2013, (submitted for publication).
24. Henry R.L., Mellis C.M., Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr. Pulmonol. 1992, 12:158.
25. Holzapfel L., Chastang C., Demingeon G., Bohe J., Piralla B., Coupry A. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 1999, 159:695.
26. Howarth P.H., Persson C.G., Meltzer E.O., Jacobson M.R., Durham S.R., Silkoff P.E. Objective monitoring of nasal airway inflammation in rhinitis. J. Allergy Clin. Immunol. 2005, 115:S414.
27. Kerem E., Corey M., Gold R., Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J. Pediatr. 1990, 116:714.
28. Kirkeby L., Rasmussen T.T., Reinholdt J., Kilian M. Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria. Clin. Diagn. Lab. Immunol. 2000, 7:31.
29. Klimek L., Reske-Kunz A.B., Malling H.J. Methods for monitoring of therapeutic efficacy in immunotherapy of allergic rhinitis. Wien. Med. Wochenschr. 1999, 149:394.
30. Leynaert B., Neukirch F., Demoly P., Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J. Allergy Clin. Immunol. 2000, 106:S201.
31. Lu F.X., Esch R.E. Novel nasal secretion collection method for the analysis of allergen specific antibodies and inflammatory biomarkers. J. Immunol. Methods 2010, 356:6.
32. Mainz J.G., Naehrlich L., Schien M., Kading M., Schiller I., Mayr S., Schneider G., Wiedemann B., Wiehlmann L., Cramer N., Pfister W., Kahl B.C., Beck J.F., Tummler B. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax 2009, 64:535.
33. Mainz J.G., Michl R., Pfister W., Beck J.F. Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation. Am. J. Respir. Crit. Care Med. 2011, 184:1089.
34. Mainz J.G., Hentschel J., Schien C., Cramer N., Pfister W., Beck J.F., Tummler B. Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation. J. Cyst. Fibros. 2012, 11:158.
35. Maremmani C., Fattori B., De Ciccio M., Ceravolo R., Ghilardi P.L., Muratorio A. Electrophoretic pattern of physiological human nasal secretions. Rhinology 1996, 34:147.
36. Naclerio R.M., Meier H.L., Kagey-Sobotka A., Adkinson N.F., Meyers D.A., Norman P.S., Lichtenstein L.M. Mediator release after nasal airway challenge with allergen. Am. Rev. Respir. Dis. 1983, 128:597.
37. Naranbhai V., Bartman P., Ndlovu D., Ramkalawon P., Ndung'u T., Wilson D., Altfeld M., Carr W.H. Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function. J. Immunol. Methods 2011, 366:28.
38. Nikasinovic-Fournier L., Just J., Seta N., Callais F., Sahraoui F., Grimfeld A., Momas I. Nasal lavage as a tool for the assessment of upper-airway inflammation in adults and children. J. Lab. Clin. Med. 2002, 139:173.
39. Ortiz E., Ng R.T.Y., Alliegro F.C., Teixeira C., Muranaka E.B., Sakano E. Microbiology of rhinosinusitis in immunosuppressed patients from the university hospital. Braz. J. Otorhinolaryngol. 2011, 77:522.
40. Ostertag E.M., Goodier J.L., Zhang Y., Kazazian H.H. SVA elements are nonautonomous retrotransposons that cause disease in humans. Am. J. Hum. Genet. 2003, 73:1444.
41. Pitrez P.M., Brennan S., Turner S., Sly P.D. Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis. Respirology 2005, 10:177.
42. Rasmussen J., Aanæs K., Norling R., Nielsen K.G., Johansen H.K., von Buchwald C. CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. J. Cyst. Fibros. 2012, 11:93.
43. Rogers G.B., Carroll M.P., Zain N.M.M., Bruce K.D., Lock K., Walker W., Jones G., Daniels T.W.V., Lucas J.S. Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia. J. Clin. Microbiol. 2013, 51:4029.
44. Rowe S.M., Miller S., Sorscher E.J. Cystic fibrosis. N. Engl. J. Med. 2005, 352:1992.
45. Ruocco L., Fattori B., Romanelli A., Martelloni M., Casani A., Samolewska M., Rezzonico R. A new collection method for the evaluation of nasal mucus proteins. Clin. Exp. Allergy 1998, 28:881.
46. Semik-Orzech A., Barczyk A., Wiaderkiewicz R., Pierzchala W. Interleukin 17 and RANTES levels in induced sputum of patients with allergic rhinitis after a single nasal allergen challenge. Ann. Allergy Asthma Immunol. 2009, 103:418.
47. Soane R.J., Carney A.S., Jones N.S., Frier M., Perkins A.C., Davis S.S., Illum L. The effect of the nasal cycle on mucociliary clearance. Clin. Otolaryngol. Allied Sci. 2001, 26:9.
48. Spong C.Y., Ghidini A., Ossandon M., Walker C.N., Pezzullo J.C. Are the cytokines interleukin-6 and angiogenin stable in frozen amniotic fluid?. Am. J. Obstet. Gynecol. 1998, 178:783.
49. Suerbaum S.E.A. Physiologische Bakterienflora. Med.Mikrobiol.Infektiol. 2012, 26.
50. Walsh E.E., Falsey A.R. A simple and reproducible method for collecting nasal secretions in frail elderly adults, for measurement of virus-specific IgA. J. Infect. Dis. 1999, 179:1268.
51. Wang D.Y., Clement P. Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis. Am. J. Rhinol. 2000, 14:325.
52. Watelet J.B., Gevaert P., Holtappels G., Van Cauwenberge P., Bachert C. Collection of nasal secretions for immunological analysis. Eur. Arch. Otorhinolaryngol. 2004, 261:242.
53. Weidenmaier C., Goerke C., Wolz C. Staphylococcus aureus determinants for nasal colonization. Trends Microbiol. 2012, 20:243.
54. Yamazaki M., Kimura K., Watanabe S., Komiyama O., Mishiku Y., Yamamoto K., Sugaya N., Hashimoto Y., Hagiwara N., Maezawa T., Imai M. Use of a rapid detection assay for influenza virus, on nasal aspirate specimens. Kansenshogaku Zasshi. 1999, 73:1064.